A Charleston medical company has been selected to join a SCRA Technology Ventures program that offers support to emerging businesses.
ToleRaM Nanotech is a bio-engineering firm formed by a transplant surgeon and two research scientists at the Medical University of South Carolina. It is working on synthesizing tiny particles to be used in anti-rejection treatments for organ recipients. Its initial findings were presented at the State of the Art Winter Symposium of the American Society of Transplant Surgeons in January 2014, according to MUSC.
ToleRaM was selected as a “client company” of SC Launch, meaning it will receive mentoring and other support services. The company also could become eligible to receive funding from the S.C. Research Authority’s investment arm.
Its founders are Dr. Ann-Marie Broome, Dr. Satish N. Nadig and Dr. Carl Atkinson.